Harmonizing the craft of crafting clinically endorsed small-molecule BCR-ABL tyrosine kinase inhibitors for the treatment of hematological malignancies
- Resource Type
- Review Article
- Source
- In
European Journal of Pharmaceutical Sciences 1 February 2024 193 - Subject
- Language
- ISSN
- 0928-0987